There is an increased risk of cognitive impairment or dementia in women who undergo bilateral salpingo-oophorectomy (BSO) before menopause. However, data are lacking on the association of BSO before menopause with imaging biomarkers that indicate medial temporal lobe neurodegeneration and Alzheimer disease pathophysiology.
W omen who undergo bilateral salpingo-oophorectomy (BSO) before the onset of menopause have an accelerated accumulation of multimorbidity, with an increased risk of aging-associated neurological diseases, including dementia. [1] [2] [3] Furthermore, surgical menopause at an early age was associated with Alzheimer disease (AD) pathology at autopsy. 4 Because imaging biomarkers associated with cognitive impairment and dementia precede the clinical symptoms, and may provide insight into the underlying causative mechanisms of cognitive impairment and dementia later in life, we investigated β-amyloid deposition (primary outcome), magnetic resonance imaging (MRI)-based biomarkers of medial temporal lobe neurodegeneration, and white matter hyperintensity volume in women who underwent BSO before age 50 years and before reaching natural menopause.
Methods
The Mayo Clinic Cohort Study of Oophorectomy and Aging-2 (MOA-2) is a population-based cohort study that includes women who underwent BSO before age 50 years and before reaching natural menopause from 1988 through 2007 and an age-matched control group who had not undergone bilateral oophorectomy before age 50 years. 5 The Mayo Clinic Study of Aging (MCSA) is another population-based cohort study, which includes participants with normal cognitive aging, mild cognitive impairment, and dementia. 6 All MCSA participants are invited to undergo MRI and Pittsburgh compound B (PiB) positron emission tomography (PET). Both study cohorts are representative of the geographically defined population of Olmsted County, Minnesota. In the current study, women with BSO and control-participant women from the MOA-2 cohort who later were enrolled in the MCSA and underwent a neuropsychological evaluation, MRI, and PiB-PET scan were included ( Figure 1 ). This study was approved by the Mayo Clinic institutional review board, and written informed consent was obtained from all participants. Global cognitive status was assessed using the short test of mental status, and combining 9 tests into a global cognitive status score. 6 The MRI studies were performed at 3-T (GE Healthcare). Previously described and validated MRI analysis methods were used. 7, 8 Hippocampal and amygdala volumes were adjusted for total intracranial volume. Parahippocampal-entorhinal cortical thickness was measured using FreeSurfer version 5.3 (Athinoula A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital). 9 A semi-automated segmentation 10 of fluidattenuated inversion recovery (FLAIR) images was used for white matter hyperintensity volume quantification and adjusted for total intracranial volume. Cerebral infarcts were also evaluated. Previously described and validated methods were used to process diffusion tensor imaging scans. 11 Entorhinal white matter fractional anisotropy, which includes the perforant pathway, was quantified using the Johns Hopkins University atlas. 12 A PET and computed tomography scanner with 3-dimensional mode (GE Healthcare) was used for PET imaging, and image analysis was performed using an automated image processing pipeline. 8 Cortical β-amyloid deposition on PiB-PET scan was calculated using standard uptake value ratio.
Statistical Analysis
Wilcoxon rank sum tests, rank regression tests adjusted for total intracranial volume, and Fisher exact tests were used for comparisons of the BSO and control groups. Correlations between imaging biomarkers and global cognitive status scores were assessed using Spearman correlations, and the P values were adjusted for multiple comparisons using the falsediscovery rate. Statistical significance was considered at the 2-sided α level of .05. 
Key Points
Question Do women who underwent bilateral salpingooophorectomy before menopause show greater medial temporal lobe structural changes, β-amyloid accumulation, and white matter lesion load on neuroimaging later in life compared with a control group?
Findings In this case-control study, women with bilateral salpingo-oophorectomy before menopause had smaller amygdala volumes, thinner parahippocampal-entorhinal cortices, and lower entorhinal white matter fractional anisotropy values compared with control participants.
Meaning Abrupt hormonal changes associated with bilateral salpingo-oophorectomy in premenopausal women may lead to medial temporal lobe structural abnormalities later in life; because alterations in structural imaging biomarkers of the medial temporal lobe neurodegeneration may precede clinical symptoms of dementia, longitudinal follow-up of this cohort with cognitive testing is necessary.
with the control group (n = 1 [5%]; P = .40), the short test of mental status, global cognitive status scores, and the Beck depression and anxiety inventory scores did not differ between the groups (Table) . (Table) . Smaller hippocampal volume on MRI and higher cortical PiB standard uptake value ratio on PiB-PET scan were observed in the BSO group compared with the control group, but these results did not reach statistical significance ( Figure 2) . The results did not change noticeably in sensitivity analyses that added 4 women who had an MRI but not a PiB-PET scan, and in sensitivity analyses that removed 4 women who had mild cognitive impairment at the time of imaging testing (data not shown). White matter hyperintensity volume and the frequency of infarctions did not differ between the groups. Imaging biomarkers were not associated with the global cognitive status score, and Beck Anxiety Inventory and Beck Depression Inventory scores after correcting for multiple comparisons using false-discovery rate.
Discussion
In this study, women who underwent BSO before age 50 years and before reaching natural menopause had smaller amygdala volumes, thinner parahippocampal-entorhinal cortices, and lower entorhinal white matter fractional anisotropy values compared with control-participant women.
There is an increased risk of cognitive impairment or dementia 1 and presence of AD pathology 4 in women who undergo BSO before menopause. However, imaging biomarkers associated with AD pathophysiology that precede cognitive impairment have not been studied in these women. Results of the present study suggest that women who underwent early BSO have biomarker abnormalities associated with neurodegeneration in the medial temporal lobe. In particular, the entorhinal cortex, which is one of the regions involved with neurofibrillary tangle pathology during the preclinical stages of AD, as well as primary ageassociated taupathy. 14 In addition, a thinner entorhinal cortex and lower fractional anisotropy on diffusion tensor imaging in the BSO group suggest a disruption in the entorhinal white matter microstructure that includes the perforant pathway carrying the connections between the entorhinal cortex and the hippocampus. Although not statistically significant in this small explorative sample, a difference in hippocampal volumes and cortical PiB uptake in the BSO group compared with the control group suggests the occurrence of early biomarker changes associated with AD pathophysiology. Premenopausal oophorectomy-induced estrogen deficiency is thought to be the primary cause of the increased risk of cognitive impairment or dementia in women with BSO before the onset of menopause. 1 Furthermore, AD biomarker abnormalities have been observed more frequently in women undergoing menopause compared with premenopausal women, after controlling for age. 15 In our study, 96% of the women with BSO were treated with estrogen (primarily oral conjugated equine estrogen), for a median of 10 years after BSO; however, this type and duration of hormonal treatment after BSO does not seem to be sufficient to prevent structural changes in the medial temporal lobe later in life. Further research into the type of estrogen treatments used, route of administration, dosing, and influence of the other ovarian hormones and hormones of the pituitary-ovarian axis is needed. 
Limitations
Lower hippocampal volume and higher cortical β-amyloid accumulation observed in the BSO group compared with the control group may have failed to reach statistical significance because of the small sample size. Because structural imaging biomarkers of medial temporal lobe neurodegeneration are associated with cognitive impairment and dementia later in life, 16 findings of the current study support the association between BSO in premenopausal women and an increased risk of cognitive decline and dementia.
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Conclusions
Abrupt hormonal changes because of BSO in premenopausal women may lead to medial temporal lobe structural abnormalities later in life. Because alterations in structural imaging biomarkers of neurodegeneration in the medial temporal lobe precede clinical symptoms of dementia, enlargement and longitudinal follow-up of this cohort is needed. 
Control Participants
Box plots show median and interquartile ranges. Amygdala volume was smaller and parahippocampal-entorhinal cortex was thinner on structural magnetic resonance imaging, and entorhinal white matter fractional anisotrophy was lower on diffusion tensor imaging in women who had undergone BSO than in control participants. Hippocampal volume was calculated as raw right plus left hippocampal volumes, adjusted for total intracranial volume. To derive the total intracranial volume-adjusted hippocampal volume, we fit a linear regression model among 133 participants with normal cognitive function aged 30 to 59 years to predict hippocampal volume from total intracranial volume.
13 There were no statistically significant differences in hippocampal volume, cortical Pittsburgh compound B (PiB) standard uptake value ratio, or white matter hyperintensity volume between women who had undergone BSO and control participants. 
